Yield10 Bioscience to Present at the SeeThruEquity Microcap Investor Conference
WOBURN, MA / ACCESSWIRE / May 30, 2017 / Yield10 Bioscience, Inc. (YTEN) announced today that Oliver Peoples, Ph.D., President and Chief Executive Officer, will present at the SeeThruEquity 6th Annual Microcap Investor Conference on Thursday, June 1, 2017 at 10:30 am EDT. The conference will be held at Convene 101 Park Avenue in New York City. Management will also be meeting with members of the investment community during one-on-one meetings.
A live audio webcast and copy of the presentation can be accessed through the "Investors" section of the Company's website at www.yield10bio.com. Interested parties unable to listen to the live webcast can access an archived version on the Company's website for approximately 90 days.
News Compliments of ACCESSWIRE.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean, and corn. Yield10 is based in Woburn, MA.
For more information about the company, please visit www.yield10bio.com.
(YTEN-G)
About SeeThruEquity
Since the company's founding in 2011, SeeThruEquity (STE) has been committed to its core mission: providing impactful, high quality research on uncovered and undercovered microcap stocks and hosting investor conferences throughout the year. STE has been able to grow its research universe to over 190 names.
STE conferences are the ultimate event for publicly traded companies with less than $1 billion in market capitalization because it augments the conference experience with the firm's research, which is part of Wall Street consensus and available across industry leading platforms including Thomson First Call, FactSet, S&P CapitalIQ, Yahoo! Finance, and Bloomberg, to name a select few. STE has hosted over 23 investor conferences which have showcased over 400 companies, attracted over 5000 attendees and have included over 2000 1-on-1 meetings. For more information, please visit www.seethruequity.com/conference/.
Contacts:
Yield10 Bioscience:
Lynne H. Brum
(617) 682-4693
LBrum@yield10bio.com
Investor Relations Contact:
Amato and Partners, LLC
90 Park Avenue, 17th Floor
New York, NY 10016
admin@amatoandpartners.com
SOURCE: Yield10 Bioscience, Inc.
